PERSPECTA

News from every angle

Back to headlines

Sam Altman-Backed Retro Biosciences Increases Dosage in Alzheimer's Drug Trial

The longevity biotech startup led by Joe Betts-LaCroix is advancing its clinical testing of an Alzheimer's treatment pill following preliminary results that showed limited efficacy.

26 Aug, 15:51 — 26 Aug, 15:51
PostShare